Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
Elisabetta Molteni, Elisa Bono, Anna Gallí, et al.
Blood (2023) Vol. 142, Iss. 7, pp. 643-657
Open Access | Times Cited: 14

Showing 14 citing articles:

Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Diagnosis and classification of myelodysplastic syndromes
Robert P. Hasserjian, Ulrich Germing, Luca Malcovati
Blood (2023) Vol. 142, Iss. 26, pp. 2247-2257
Closed Access | Times Cited: 23
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 652-652
Open Access | Times Cited: 4
Progress in medical therapy in aplastic anemia: why it took so long?
Phillip Scheinberg
International Journal of Hematology (2024) Vol. 119, Iss. 3, pp. 248-254
Open Access | Times Cited: 4
Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
Jörg Cammenga
Experimental Hematology (2024) Vol. 134, pp. 104217-104217
Open Access | Times Cited: 3
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
Cristian C. Taborda, Amer M. Zeidan, Lourdes M. Mendez
Frontiers in Hematology (2024) Vol. 3
Closed Access | Times Cited: 1
Novel insights and therapeutic approaches in secondary AML
Giovanni Marconi, Michela Rondoni, Beatrice Anna Zannetti, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Germline DDX41 mutant predisposition syndromes: Slow driver states to hematological malignancies
Timothy M. Chlon, Mrinal M. Patnaik
American Journal of Hematology (2023) Vol. 98, Iss. 11, pp. 1673-1676
Closed Access | Times Cited: 2
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
(2023)
Open Access | Times Cited: 2
Germline assessment for alloHSCT candidates over 50 years: A ‘Fast‐Track’ screening in myeloid neoplasms
Sara Torres‐Esquius, F Beas, Tzu Hua Chen‐Liang, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 2, pp. 503-509
Closed Access
Characterization and Clinical Outcome of Philadelphia Chromosome–Positive AML in Thrombocytopenia-Absent Radius Syndrome
Alejandro Villar‐Prados, Arman Odabas, Joshua Menke, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Spinocerebellar ataxia type 49 presenting with ataxia, early onset dystonia, and bradykinesia in an Indian female patient
Divyani Garg, Pooja Sharma, Mohammed Faruq, et al.
Parkinsonism & Related Disorders (2024) Vol. 130, pp. 107188-107188
Closed Access
Clonal hematopoiesis in cancer predisposition syndromes
Kenichi Yoshida
International Journal of Hematology (2024)
Closed Access
Germ line risk variants: beyond cancer
Lucy A. Godley
Blood (2023) Vol. 142, Iss. 7, pp. 616-617
Closed Access
Page 1

Scroll to top